A chronic outcome of shock wave lithotripsy is parenchymal fibrosis

Research output: Contribution to journalArticle

13 Scopus citations

Abstract

Shock wave lithotripsy (SWL) is widely viewed as an effective noninvasive method to break stones within the kidney and ureter. However, it is a technology that is not without trauma to the kidney-acute vascular, tubular and interstitial damage is often reported that if severe enough can lead to renal fibrosis (scarring) and permanent loss of functional parenchyma. These chronic changes can potentially lead to serious long-term adverse effects. The risk of developing chronic fibrotic lesions after lithotripsy is influenced by the number of shock waves (SWs) administered, SW power, rate of SW delivery and the number of SWL treatment sessions. The interplay between these risk factors is largely unknown, but progress has been made in identifying SWL protocols and pharmacologic therapies that can ameliorate the acute and chronic tissue damage that is an unintended consequence of SWL treatment.

Original languageEnglish (US)
Pages (from-to)301-305
Number of pages5
JournalUrological Research
Volume38
Issue number4
DOIs
StatePublished - Aug 1 2010

Keywords

  • Fibrosis
  • Kidney
  • Shock wave lithotripsy

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'A chronic outcome of shock wave lithotripsy is parenchymal fibrosis'. Together they form a unique fingerprint.

  • Cite this